Literature DB >> 2158220

15-HETE inhibits leukotriene B4 formation and synovial cell proliferation in experimental arthritis.

T Herlin1, K Fogh, E S Hansen, A Andreasen, V Knudsen, T B Henriksen, C Bunger, K Kragballe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2158220     DOI： 10.1007/BF01964718

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  5 in total

1.  Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE).

Authors:  K Fogh; H Søgaard; T Herlin; K Kragballe
Journal:  J Am Acad Dermatol       Date:  1988-02       Impact factor: 11.527

2.  Changes in lipoxygenase products from synovial fluid in carrageenan induced arthritis in dogs.

Authors:  T Herlin; K Fogh; H Ewald; E S Hansen; V E Knudsen; I Holm; K Kragballe; C Bunger
Journal:  APMIS       Date:  1988-07       Impact factor: 3.205

3.  15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4).

Authors:  K Fogh; E S Hansen; T Herlin; V Knudsen; T B Henriksen; H Ewald; C Bünger; K Kragballe
Journal:  Prostaglandins       Date:  1989-02

4.  Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.

Authors:  J Y Vanderhoek; R W Bryant; J M Bailey
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

5.  15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.

Authors:  T Ternowitz; K Fogh; K Kragballe
Journal:  Skin Pharmacol       Date:  1988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.